Skip to main content Help with accessibility Skip to main navigation

MIRABEGRON prolonged-release tablets (Betmiga®▼)

CCG Approval Status:

Date Added: 10 - Jul - 2013
Body System:
Green

The Pan Mersey Area Prescribing Committee recommends the prescribing of MIRABEGRON prolonged-release tablets (Betmiga®▼) for overactive bladder syndrome (OAB) in accordance with NICE TA290.